Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment

Conditions:   Rhegmatogenous Retinal Detachment;   Proliferative Vitreoretinopathy Intervention:   Drug: Netarsudil Ophthalmic Sponsor:   Massachusetts Eye and Ear Infirmary Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials